FIELD: organic chemistry, medicine, oncology, pharmacy.
SUBSTANCE: invention relates to new heteroaryl derivatives, in particular, derivatives of quinoline of he general formula (I): wherein R, R1, R2 and R3 are similar or different and mean independently of one another hydrogen atom, linear or branched (C1-C8)-alkyl, halogen atom, aryl-(C1-C8)-alkoxy-group, aryl. Except for, R and R1 or R2 and R3 can form six-membered aromatic ring condensed with quinoline residue; X means oxygen atom; p, Q mean in each case -CH2-; X means nitrogen atom; n = 2; m = 0; R4 means phenyl or pyridyl. Also, invention relates to their pharmaceutically acceptable salts, in particular, acid-additive salts. Compounds are useful as antitumor agents. Also, invention describes a method for preparing compounds and medicinal agent based on thereof.
EFFECT: improved preparing method, valuable medicinal properties of compounds and agent.
11 cl, 2 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
INDOLE DERIVATIVES, METHOD FOR THEIR PREPARING, MEDICINAL AGENT AND METHOD FOR INHIBITION OF TUMOR CELLS PROLIFERATION | 2001 |
|
RU2270196C9 |
ACRIDINE DERIVATIVES, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2267488C2 |
DERIVATIVES OF (THIO)UREA INHIBITING VIIa FACTOR, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2286337C2 |
USING SIP RECEPTOR MODULATORS IN OPHTHALMOLOGY | 2006 |
|
RU2497513C2 |
COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR | 2007 |
|
RU2481840C2 |
CONDENSED HETEROCYCLIC COMPOUND | 2009 |
|
RU2480473C2 |
METHOD OF TREATING POLYCYSTIC KIDNEY DISEASES BY CERAMIDE DERIVATIVES | 2008 |
|
RU2517345C9 |
SUBSTITUTED BICYCLIC COMPOUNDS, PARENT AND INTERMEDIATE SUBSTANCES FOR THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1998 |
|
RU2203272C2 |
HETEROCYCLIC COMPOUND, METHOD FOR ITS PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2221792C2 |
DERIVATIVES OF N-SUBSTITUTED INDOLE-3-GLYOXYLAMIDE AS ANTITUMOR MEDICINAL AGENT AND AGENT INHIBITING ANGIOGENESIS (VARIANTS) AND ANTITUMOR MEDICINAL AGENT (VARIANTS) | 2000 |
|
RU2282444C2 |
Authors
Dates
2005-12-10—Published
2001-07-18—Filed